Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the Primary Prevention of Endometrial Cancer

Part of paid clinical trials in Houston, Texas.

Sponsor
M.D. Anderson Cancer Center
Study ID
NCT07382583
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Survey using a questionnaire — OTHER
    Patient Preference Utility Assessment and Questionnaires

Study Details

To develop an educational tool to help patients and healthcare professionals make informed decisions about endometrial cancer and available prevention options for it (such as the use of a levonorgestrel-releasing intrauterine system \[LNG-IUS\]).

Key Dates

Start date
Feb 12, 2026
Status verified
Feb 2026
Primary completion
Feb 1, 2028
Completion
Feb 1, 2030

Study Design

Enrollment
270 participants (estimated)

Arms

  • Arm: Phase 1
    Identify decisional needs, patient values and experiences
  • Arm: Phase 2
    Develop and pilot test a web-based shared medical decision tool

Primary Outcome Measure

Patient Utility Questionnaire [ Time Frame: Through study completion; an average of 1 year ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
MD Anderson Cancer CenterHoustonTexas77030
Larissa A Meyer, MD
[email protected]
713-745-0973
Larissa A Meyer, MD (PRINCIPAL_INVESTIGATOR)
The Harris Health System (LBJ)HoustonTexas77026
Larissa Meyer, MD
[email protected]
281-682-8359
Larissa Meyer, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in Houston, TX

By condition
Endometrial cancer
By specialty
OncologyGynecologic oncologyWomen's health
By research site
MD Anderson Cancer Center· Houston, TXThe Harris Health System (LBJ)· Houston, TX

Related Studies